European equities traded in the US as American depositary receipts were rising on Monday morning, up 1.7% to 1,741.84 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by solar energy technology company Turbo Energy (TURB) and clinical stage biotechnology company Abivax (ABVX), which rose 7.5% and 5.7% respectively. They were followed by telecommunications and consumer electronics company Nokia (NOK), which added 4.3%.

The decliners from continental Europe were led by biotech company Evaxion (EVAX) and construction engineering company Cadeler (CDLR), which fell 7.3% and 4% respectively. They were followed by clinical stage biopharmaceutical company DBV Technologies (DBVT), which was down 0.8%.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics (SLN) and cruise line operator Carnival (CUK), which rose 5.9% and 3.8% respectively.

The decliners from the UK and Ireland were led by oncology biotech company Akari Therapeutics (AKTX) and clinical stage biotech company Biodexa Pharmaceuticals (BDRX), which lost 7.7% and 4% respectively.